TD Cowen Expects a 'Good 2Q' for Abbott Labs (ABT)

July 11, 2025 10:30 AM EDT Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $145.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login